Literature DB >> 16809182

Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.

Kevin Irwin1, Evgeni Karchevsky, Robert Heimer, Larissa Badrieva.   

Abstract

Effective prevention of syringe-borne transmission of HIV and the hepatitis viruses can be undermined if contact between injection drug users and the staff of prevention programs is impeded by police harassment, limited program resources, and the absence of an open "drug scene." All these are commonplace in the Russian Federation. In response, "Project Renewal," the harm reduction program of the AIDS Prevention and Control Center of the Tatarstan Ministry of Health in Kazan, has created a hybrid syringe exchange program that as its primary focus recruited and trained volunteers to provide secondary syringe exchange. To compensate for operational barriers, the program staff identified private venues and trained responsible individuals to work through their own and related networks of injectors to provide clean syringes, other harm reduction supplies, and educational materials, while facilitating the collection and removal of used and potentially contaminated syringes. Program staff developed a detailed set of tracking instruments to monitor, on a daily and weekly basis, the locations and types of contacts and the dissemination of trainings and materials to ensure that the secondary distribution network reaches its target audience. Data show that these secondary exchange sites have proven more productive than the primary mobile and fixed-site syringe exchanges in Kazan. Beginning in 2001, Project Renewal has trained other harm reduction programs in the Russian Federation to use this model of reaching injectors, identifying and training volunteers, and monitoring results of secondary syringe exchange.

Entities:  

Mesh:

Year:  2006        PMID: 16809182     DOI: 10.1080/10826080600667219

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  9 in total

Review 1.  Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward.

Authors:  Mukta Sharma; Dave Burrows; Ricky Bluthenthal
Journal:  Int J Drug Policy       Date:  2007-01-02

2.  A qualitative assessment of injection drug use and harm reduction programmes in Kabul, Afghanistan: 2006-2007.

Authors:  Catherine S Todd; Mark A Stibich; M Raza Stanekzai; M Zafar Rasuli; Shairshah Bayan; Saifur Rehman Wardak; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2008-01-22

3.  The distinctive roles of urban community health workers in low- and middle-income countries: a scoping review of the literature.

Authors:  Teralynn Ludwick; Alison Morgan; Sumit Kane; Margaret Kelaher; Barbara McPake
Journal:  Health Policy Plan       Date:  2020-10-01       Impact factor: 3.344

4.  A GIS-based methodology for improving needle exchange service delivery.

Authors:  Peter J Davidson; Shoshanna Scholar; Mary Howe
Journal:  Int J Drug Policy       Date:  2010-11-27

5.  Decreased Odds of Injection Risk Behavior Associated With Direct Versus Indirect Use of Syringe Exchange: Evidence From Two California Cities.

Authors:  Czarina N Behrends; Chin-Shang Li; David R Gibson
Journal:  Subst Use Misuse       Date:  2017-05-30       Impact factor: 2.164

6.  A reexamination of connectivity trends via exponential random graph modeling in two IDU risk networks.

Authors:  Kirk Dombrowski; Bilal Khan; Katherine McLean; Ric Curtis; Travis Wendel; Evan Misshula; Samuel Friedman
Journal:  Subst Use Misuse       Date:  2013-07-02       Impact factor: 2.164

7.  Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish city.

Authors:  Julie Holeksa
Journal:  Harm Reduct J       Date:  2022-03-04

8.  Task shifting redefined: removing social and structural barriers to improve delivery of HIV services for people who inject drugs.

Authors:  Lianping Ti; Thomas Kerr
Journal:  Harm Reduct J       Date:  2013-10-04

9.  Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?

Authors:  Zoe Ward; Lucy Platt; Sedona Sweeney; Vivian D Hope; Lisa Maher; Sharon Hutchinson; Norah Palmateer; Josie Smith; Noel Craine; Avril Taylor; Natasha Martin; Rachel Ayres; John Dillon; Matthew Hickman; Peter Vickerman
Journal:  Addiction       Date:  2018-05-17       Impact factor: 6.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.